Neurotech Startup Neurovalens Receives FDA Clearance for Noninvasive Anxiety Treatment
Neurovalens, a Belfast-based startup specializing in noninvasive electrical stimulation of the brain and nervous system, has achieved a significant milestone with the FDA clearance of its second head-mounted treatment device. This approval follows its first FDA clearance for a device targeting insomnia, with the latest approval focusing on treating generalized anxiety disorder (GAD). The company aims to address chronic conditions like obesity-related cardiometabolic risk and PTSD in the future. Devamını Oku



